Depression and cognition scores revealed significantly less worsening in the rasagiline group compared with the placebo group ( differences in Movement Disorder Society-sponsored revision of the Unified Parkinson 's Disease Rating Scale item-adjusted means -LSB- SEs -RSB- , -@ -LSB- @ -RSB- , P = @ , and -@ -LSB- @ -RSB- , P < @ , respectively ) .